Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:54
Man shares emotional testimony during congressional hearing after...
-
2:45
Steil seeks fourth term while Barca looks to pull off upset
-
1:29
Betty Brinn Children’s Museum hosts Betty BOO’s Spooktacular
-
3:13
Milwaukee WNBA team proposal; women’s coaches and sports fans...
-
1:05
Second Gentleman Doug Emhoff, Doc Rivers rally for Harris on...
-
2:00
’Mitchell Park will live on’: Proposal to restore Mitchell...
-
0:54
Groundbreaking held for 1st phase of Kenosha’s Harbor District
-
1:30
We Energies hosts annual Great Cookie Book Taste Off
-
1:13
Serving those who served: Journey21 in Oconomowoc makes chili...
-
2:25
Early voters in Milwaukee continue to head to polls in large...
-
2:04
Car crashes into Racine home, massive house fire breaks out
-
1:02
Sen. Ron Johnson discusses border policy during Milwaukee visit
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.